Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Magini

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Heart Failure|March 15, 2006
Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxiaPiergiuseppe Agostoni, Mauro Contini, Alessandra Magini, et al.
Journal of the American College of Cardiology|May 22, 2007
Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathyDaniele Andreini, Gianluca Pontone, Mauro Pepi, et al.
European Journal of Preventive Cardiology|April 12, 2020
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit?Andrea Segreti, Francesco Grigioni, Jeness Campodonico, et al.
Scientific Reports|April 30, 2020
Effects of β<sub>2</sub>-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trialMauro Contini, Emanuele Spadafora, Simone Barbieri, et al.
Respiratory Physiology & Neurobiology|June 9, 2020
Variability in pulmonary diffusing capacity in heart failureAlessandra Magini, Mauro Contini, Emanuele Spadafora, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fractionMassimo Mapelli, Elisabetta Salvioni, Fabiana de Martino, et al.
European Journal of Preventive Cardiology|February 14, 2019
Isocapnic buffering period: From physiology to clinicsCosimo Carriere, Ugo Corrà, Massimo Piepoli, et al.
Cardiovascular Therapeutics|June 18, 2010
Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker doseDamiano Magrì, Pietro Palermo, Filippo M Cauti, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 4, 2021
Minute ventilation/carbon dioxide production in chronic heart failurePiergiuseppe Agostoni, Susanna Sciomer, Pietro Palermo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Rationale and design of the EPLURIBUS Study (Evidence for a comPrehensive evaLUation of left ventRicle dysfnctIon By a whole-heart coverage cardiac compUted tomography Scanner)Daniele Andreini, Edoardo Conte, Saima Mushtaq, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Heart Failure|March 15, 2006
Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxiaPiergiuseppe Agostoni, Mauro Contini, Alessandra Magini, et al.
Journal of the American College of Cardiology|May 22, 2007
Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathyDaniele Andreini, Gianluca Pontone, Mauro Pepi, et al.
European Journal of Preventive Cardiology|April 12, 2020
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit?Andrea Segreti, Francesco Grigioni, Jeness Campodonico, et al.
Scientific Reports|April 30, 2020
Effects of β<sub>2</sub>-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trialMauro Contini, Emanuele Spadafora, Simone Barbieri, et al.
Respiratory Physiology & Neurobiology|June 9, 2020
Variability in pulmonary diffusing capacity in heart failureAlessandra Magini, Mauro Contini, Emanuele Spadafora, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fractionMassimo Mapelli, Elisabetta Salvioni, Fabiana de Martino, et al.
European Journal of Preventive Cardiology|February 14, 2019
Isocapnic buffering period: From physiology to clinicsCosimo Carriere, Ugo Corrà, Massimo Piepoli, et al.
Cardiovascular Therapeutics|June 18, 2010
Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker doseDamiano Magrì, Pietro Palermo, Filippo M Cauti, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 4, 2021
Minute ventilation/carbon dioxide production in chronic heart failurePiergiuseppe Agostoni, Susanna Sciomer, Pietro Palermo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Rationale and design of the EPLURIBUS Study (Evidence for a comPrehensive evaLUation of left ventRicle dysfnctIon By a whole-heart coverage cardiac compUted tomography Scanner)Daniele Andreini, Edoardo Conte, Saima Mushtaq, et al.
Pageof 3